Maximizing the catheter-to-vessel size optimizes distal flow control resulting in improved revascularization in vitro for aspiration thrombectomy
Background
Balloon guide catheters (BGCs) achieve proximal flow control during thrombectomy but antegrade intracranial flow often persists via the Circle of Willis. Closely sizing an aspiration catheter to the target vessel might achieve greater flow control and improve technical performance. Our objective was to measure the impact of aspiration catheter size on distal flow control and flow reversal with and without the use of BGCs. Clot retrieval testing was performed to establish the impact of these parameters on revascularization.
Methods
An in vitro thrombectomy model replicated in vivo conditions. Flow was measured continuously using ultrasonic flow sensors placed 20 cm distal to the catheter tip in the middlel cerebral artery (MCA). Four aspiration catheters of increasing size were evaluated: ACE 60 and 64 (Penumbra), SOFIA Plus (MicroVention), and Millipede 088 (Perfuze). Two clot analog types (red blood cell-rich and fibrin/platelet-rich) were used for clot retrieval testing.
Results
The larger area of the ‘superbore’ Millipede 088 catheter resulted in a larger reduction in antegrade flow than standard aspiration catheters, even when the latter were combined with a BGC. During aspiration, 6Fr catheters were unable to cause flow reversal in the distal MCA while the Millipede 088 achieved significant distal flow reversal (−146 mL/min) (P<0.0001*) (*denotes significance). The solo use of Millipede 088 resulted in better recanalization outcomes and significantly reduced distal emboli for internal carotid artery (P=0.015*) and MCA (P=0.014*) occlusions compared with all other devices and combinations.
Conclusions
Maximizing the catheter-to-vessel size facilitates near flow-arrest on catheter insertion, potentially negating the need for a BGC. A 0.088 inch aspiration catheter enables significant flow reversal in the distal MCA during aspiration.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Journal of NeuroInterventional Surgery
15 publications, 32.61%
|
|
|
Interventional Neuroradiology
9 publications, 19.57%
|
|
|
Stroke Vascular and Interventional Neurology
4 publications, 8.7%
|
|
|
Cardiovascular Engineering and Technology
2 publications, 4.35%
|
|
|
European Stroke Journal
2 publications, 4.35%
|
|
|
Stroke
2 publications, 4.35%
|
|
|
Frontiers in Cardiovascular Medicine
1 publication, 2.17%
|
|
|
Frontiers in Medical Technology
1 publication, 2.17%
|
|
|
Frontiers in Neurology
1 publication, 2.17%
|
|
|
World Neurosurgery
1 publication, 2.17%
|
|
|
Clinical Neuroradiology
1 publication, 2.17%
|
|
|
Journal of Neuroimaging
1 publication, 2.17%
|
|
|
Neurointervention
1 publication, 2.17%
|
|
|
Frontiers in Bioengineering and Biotechnology
1 publication, 2.17%
|
|
|
World Neurosurgery: X
1 publication, 2.17%
|
|
|
BMJ Case Reports
1 publication, 2.17%
|
|
|
Interdisciplinary Neurosurgery: Advanced Techniques and Case Management
1 publication, 2.17%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
BMJ
16 publications, 34.78%
|
|
|
SAGE
10 publications, 21.74%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
6 publications, 13.04%
|
|
|
Frontiers Media S.A.
4 publications, 8.7%
|
|
|
Springer Nature
3 publications, 6.52%
|
|
|
Elsevier
3 publications, 6.52%
|
|
|
Wiley
1 publication, 2.17%
|
|
|
Korean Society of Interventional Neuroradiology
1 publication, 2.17%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 2.17%
|
|
|
World Federation of Interventional and Therapeutic Neuroradiology (WFITN)
1 publication, 2.17%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.